✦ LIBER ✦

Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy

✍ Scribed by Haruhiko Banno; Masahisa Katsuno; Keisuke Suzuki; Yu Takeuchi; Motoshi Kawashima; Noriaki Suga; Motoko Takamori; Mizuki Ito; Tomohiko Nakamura; Koji Matsuo; Shinichi Yamada; Yumiko Oki; Hiroaki Adachi; Makoto Minamiyama; Masahiro Waza; Naoki Atsuta; Hirohisa Watanabe; Yasushi Fujimoto; Tsutomu Nakashima; Fumiaki Tanaka; Manabu Doyu; Gen Sobue

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 1019 KB
Volume: 65
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.21540

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Association of spinal and bulbar muscula

Association of spinal and bulbar muscular atrophy with myotonic dystrophy type 1

✍ Kenji Jinnai; Keisuke Nishimoto; Kyoko Itoh; Kozo Hashimoto; Keiichi Takahashi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB

## Abstract A man with spinal and bulbar muscular atrophy (SBMA) had a short (CTG)n expansion in the myotonic dystrophy protein kinase gene as well as (CAG)n expansion in the androgen receptor gene in leukocytes. The patient had the characteristic clinical findings of SBMA, but none of myotonic dys

PRENATAL DIAGNOSIS OF X-LINKED SPINAL AN

PRENATAL DIAGNOSIS OF X-LINKED SPINAL AND BULBAR MUSCULAR ATROPHY IN A GREEK FAMILY

✍ CHRISTOS YAPIJAKIS; ELISABETH KAPAKI; MARINA BOUSSIOU; DIMITRIS VASSILOPOULOS; C 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 495 KB 👁 2 views

X-linked spinal and bulbar muscular atrophy (SBMA) is a late-onset motor neuron disorder which is caused by an expansion of the trinucleotide repeat (CAG), in the first exon of the androgen receptor gene. Two cases of prenatal testing for the disease in a Greek family are reported. An affected male

Somatic stability of the expanded CAG tr

Somatic stability of the expanded CAG trinucleotide repeat in X-linked spinal and bulbar muscular atrophy

✍ Roland Spiegel; Albert R. La Spada; Wolfram Kress; Kenneth H. Fischbeck; Werner 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 872 KB

Expansion of trinucleotide repeats has now been associated with eight inherited diseases: X-linked spinal and bulbar muscular atrophy, two fragile X syndromes, myotonic dystrophy, Huntington's disease, spinocerebellar ataxia type I, dentatorubral pallidoluysian atrophy and Machado-Joseph disease. It

B2 attenuates polyglutamine-expanded and

B2 attenuates polyglutamine-expanded androgen receptor toxicity in cell and fly models of spinal and bulbar muscular atrophy

✍ Isabella Palazzolo; Natalia B. Nedelsky; Caitlin E. Askew; George G. Harmison; A 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 367 KB

## Abstract Expanded polyglutamine tracts cause neurodegeneration through a toxic gain‐of‐function mechanism. Generation of inclusions is a common feature of polyglutamine diseases and other protein misfolding disorders. Inclusion formation is likely to be a defensive response of the cell to the pr

In vivo activation of SMN in spinal musc

In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate

✍ Lars Brichta; Irmgard Holker; Karsten Haug; Thomas Klockgether; Brunhilde Wirth 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 2 views

## Abstract ## Objective Spinal muscular atrophy results from loss of the survival motor neuron 1 (__SMN1__) gene and malfunction of the remaining __SMN2__. We investigated whether valproic acid can elevate human __SMN__ expression in vivo. ## Methods Blood was collected from 10 spinal muscular

Molecular and functional analysis of int

Molecular and functional analysis of intragenic SMN1 mutations in patients with spinal muscular atrophy

✍ Y. Sun; M. Grimmler; V. Schwarzer; F. Schoenen; U. Fischer; B. Wirth 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

## Communicated by Mark H. Paalman The autosomal recessive spinal muscular atrophy (SMA), a neuromuscular disease and frequent cause of early death in childhood, is caused in 96% of patients by homozygous absence of the survival motor neuron gene (SMN1). The severity of the disease is mainly deter